Skip to main content
STOK logo

STOK · Stoke Therapeutics, Inc.

$29.05 -0.06 (-0.21%) At close · Jul 17
Market Cap
$1.81B
Shares
62,281,655

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Ian F. Smith $27,031,655
Edward M. Kaye $3,234,043
Jason Hoitt $2,269,955
Thomas E. Leggett $1,830,375
Fiscal 2024
Executive Total
Edward M. Kaye $5,612,120
Thomas E. Leggett $4,520,386
Barry S. Ticho $2,469,437
Fiscal 2023
Executive Total
Edward M. Kaye $3,533,210
Barry S. Ticho $1,648,007
Stephen J. Tulipano $1,598,481
Thomas E. Leggett
Fiscal 2022
Executive Total
Edward M. Kaye $5,748,522
Barry S. Ticho $2,386,257
Stephen J. Tulipano $2,316,523
Fiscal 2021
Executive Total
Edward M. Kaye $8,543,358
Barry S. Ticho $3,149,491
Stephen J. Tulipano $3,101,566
Fiscal 2020
Executive Total
Barry S. Ticho $1,877,496
Fiscal 2019
Executive Total
Robin A. Walker $1,241,542
Stephen J. Tulipano $1,176,396
Key facts CIK 1623526 CUSIP 86150R107 13F (30d) 10 filings 10 filers Visit website Investor relations